Abstract
We have developed a sensitive, simple and cheap method for determination of lipoic acid in urine and dietary supplement tablets. The method is based on conversion of lipoic acid to its thiol counterpart – dihydrolipoic acid – by reductive cleavage with tris(2-carboxyethyl)phosphine hydrochloride prior to precolumn derivatization with 1-benzyl-2- chloropyridinium bromide, followed by ion-pairing reversed-phase liquid chromatography separation and ultraviolet detection of its 2-S-pyridinium derivative at 321 nm. Bathochromic shift from the reagent absorption maximum at 275 nm to that of derivative maximum at 321 nm, taking place during reaction, is analytically advantageous. In developing this method the following parameters were investigated and optimized: the time, pH and reagent excess in the derivatization step and mobile phase buffer concentration, pH, organic modifier and column temperature in the separation step. Calibration plot, understood as the relationship between instrument response and known concentration of the analyte, demonstrated linearity of results when applied to normal urine spiked with growing amounts of lipoic acid within the tested range 0.2 – 50 µmol/L. The method was validated for urine samples received from healthy donors and urine concentration of lipoic acid was monitored after oral administration of 600 mg of lipoic acid.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
